We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Edwards Lifesciences Acquires JV in Japan

By HospiMedica staff writers
Posted on 21 Oct 2002
Print article
A cardiovascular business in Tokyo, Japan, has been acquired by Edwards Lifesciences Corp. (Irvine, CA, USA) for about US$22 million. The business, which had been operating as a joint venture of Edwards and Baxter International, Inc. (Deerfield, IL, USA; www.baxter.com), had net sales of around $170 million in 2001. The business began in 1968 as American Hospital Supply, Japan, and now has 18 regional sales offices throughout the country.

The business provides Edwards' products for heart valve therapy, critical care medicine, vascular therapies, and cardiovascular surgery to Japanese doctors. Edwards also serves in Japan as the exclusive third-party distributor of cardiology specialty products, such as pacemakers, intra-aortic balloon pumping systems, and angioplasty catheters.

"We are confident that the addition of our strong Japanese operations will contribute toward our aspiration of becoming the global leader in innovative solutions for people fighting advanced cardiovascular disease,” said Michael A. Mussallem, chairman and CEO of Edwards Lifesciences.




Related Links:
Edwards Lifesciences
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Facet Fixation System
ZYFUSE
New
Automated External Defibrillator
HeartStart OnSite AED

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.